These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37271605)

  • 1. Retrospective Evaluation of COVID-19 Infection and COVID-19 Vaccines in Heart Transplant Patients.
    Kahraman Ü; Akyol D; Çiçek C; Balcıoğlu Ö; Engin Ç; Yağdı T; Taşbakan M; Özbaran M
    Transplant Proc; 2023 Jun; 55(5):1283-1288. PubMed ID: 37271605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant Recipients.
    Peters LL; Raymer DS; Pal JD; Ambardekar AV
    JAMA Cardiol; 2022 Jun; 7(6):651-654. PubMed ID: 35475896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 After Vaccination in Lung Transplant Recipients: Real-Life Data.
    Türkkan S; Çelik Başaran F; Şahin MF; Beyoğlu MA; Yılmaz E; Yazıcıoğlu A; Yiğit Özay H; Bindal M; Tezer Tekçe Y; Yekeler E
    Exp Clin Transplant; 2023 Mar; 21(3):265-271. PubMed ID: 35867010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Infection After Vaccination: Kidney Transplant Recipient Profile and Disease Evolution in a Single Center.
    Castelló IB; Maestre EM; Escorihuela DR; Reig JE; Galiano AV; Cebrián MR; Espinosa MM; Borrás PG; Jaras JH
    Transplant Proc; 2022; 54(6):1476-1482. PubMed ID: 35082087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
    Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
    Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients.
    Demir E; Dheir H; Safak S; Serra Artan A; Sipahi S; Turkmen A
    Vaccine; 2022 May; 40(24):3313-3319. PubMed ID: 35504784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.
    Schramm R; Costard-Jäckle A; Rivinius R; Fischer B; Müller B; Boeken U; Haneya A; Provaznik Z; Knabbe C; Gummert J
    Clin Res Cardiol; 2021 Aug; 110(8):1142-1149. PubMed ID: 34241676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort.
    Bonazzetti C; Tazza B; Gibertoni D; Pasquini Z; Caroccia N; Fanì F; Fornaro G; Pascale R; Rinaldi M; Miani B; Gamberini C; Morelli MC; Tamé M; Busutti M; Comai G; Potena L; Borgese L; Salvaterra E; Lazzarotto T; Scudeller L; Viale P; Giannella M;
    Clin Infect Dis; 2023 May; 76(10):1761-1767. PubMed ID: 36636955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
    Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
    Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of COVID 19 vaccination on kidney recipients.
    Marzieh L; Elahe P; Habib R; Maryam P; Arefeh J; Elnaz E; Sanaz D
    Transpl Immunol; 2022 Oct; 74():101658. PubMed ID: 35777613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
    Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
    Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients.
    Callaghan CJ; Mumford L; Curtis RMK; Williams SV; Whitaker H; Andrews N; Lopez Bernal J; Ushiro-Lumb I; Pettigrew GJ; Thorburn D; Forsythe JLR; Ravanan R;
    Transplantation; 2022 Mar; 106(3):436-446. PubMed ID: 34982758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Acquisition of COVID-2019 Neutralizing Antibodies in Organ Transplant Recipients.
    Akimoto S; Onoe T; Morimoto H; Yamaguchi S; Shibata Y; Tazuma S; Sada H; Shimada N; Tazawa H; Suzuki T; Sudo T; Shimizu Y; Tashiro H
    Transplant Proc; 2023 May; 55(4):815-819. PubMed ID: 37147198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
    Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A;
    JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study.
    Hall VG; Al-Alahmadi G; Solera JT; Marinelli T; Cardinal H; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Matelski J; Humar A; Kumar D
    Transplantation; 2022 Aug; 106(8):1622-1628. PubMed ID: 35502801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.